Confounding Factors (Epidemiology)Data Interpretation, StatisticalModels, StatisticalOdds RatioResearch DesignModels, GeneticStatistics as TopicBreast NeoplasmsRisk AssessmentAlgorithmsConfidence IntervalsComputer SimulationCase-Control StudiesRisk FactorsProportional Hazards ModelsIncidenceEstrogen Receptor ModulatorsPoisson DistributionUnited StatesGene Expression Regulation, NeoplasticMultivariate AnalysisLogistic ModelsTime FactorsGene Expression ProfilingSample SizeStatistical DistributionsSoftwareOligonucleotide Array Sequence AnalysisTumor Markers, BiologicalTransplantation, HeterologousPredictive Value of TestsProspective StudiesRiskReproducibility of ResultsTreatment OutcomeLikelihood FunctionsAnticarcinogenic AgentsSEER ProgramChemotherapy, AdjuvantProstatic NeoplasmsKaplan-Meier EstimateNeoplasm StagingAnalysis of VarianceLung NeoplasmsAntineoplastic Agents, HormonalAnesthesiologyGenetic VariationEvolution, MolecularBias (Epidemiology)Sequence Analysis, DNAGenotypeSelection, GeneticAntineoplastic AgentsImmunohistochemistryPolymorphism, GeneticRandomized Controlled Trials as TopicSurvival AnalysisNeoplasmsMonte Carlo MethodGenetics, PopulationMatched-Pair AnalysisDisease-Free SurvivalPhylogenyMathematical ComputingPeriodicals as TopicComputational BiologyProbabilityLinkage DisequilibriumMutationQuestionnairesBiometryMammographyRadiotherapy, AdjuvantColorectal NeoplasmsSensitivity and SpecificityPolymorphism, Single NucleotideEuropean Continental Ancestry GroupDrug Administration ScheduleScandinaviaGenetic Predisposition to DiseaseTamoxifenSelection BiasStatistics, NonparametricCluster AnalysisNeoplasms, Second PrimaryFollow-Up StudiesImmunoblottingPolymerase Chain ReactionMeta-Analysis as TopicPrognosisPostmenopauseGene FrequencyCohort StudiesMedical Record LinkageCell Line, TumorReceptors, EstrogenAge FactorsSmokingAntineoplastic Combined Chemotherapy ProtocolsTherapeutic Equivalency